索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]周刚,吴辉,刘滴,等.静脉-动脉体外膜氧合在心源性休克中的研究进展[J].国际心血管病杂志,2021,02:77-80.
点击复制

静脉-动脉体外膜氧合在心源性休克中的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年02期
页码:
77-80
栏目:
综述
出版日期:
2021-03-20

文章信息/Info

Title:
-
作者:
周刚; 吴辉; 刘滴; 李云曌
443003 宜昌,三峡大学心血管病研究所,宜昌市中心人民医院心内科
Author(s):
-
关键词:
心源性休克;  体外生命支持;  静脉-动脉体外膜氧合
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.02.004
文献标识码:
-
摘要:
静脉-动脉体外膜氧合(VA-ECMO)是目前唯一适用于严重双心室功能衰竭患者的短期循环辅助装置。近年来VA-ECMO已越来越多地用于抢救难治性心源性休克患者。该文介绍VA-ECMO在心源性休克治疗中的研究进展,进一步为VA-ECMO在心源性休克中的治疗策略提供理论基础。
Abstract:
-

参考文献/References

[1] Mebazaa A, Combes A, Van Diepen S, et al. Management of cardiogenic shock complicating myocardial infarction[J]. Intensive Care Med, 2018, 44(6):760-773.
[2] Aissaoui N, Puymirat E, Delmas C, et al. Trends in cardiogenic shock complicating acute myocardial infarction[J]. Eur J Heart Fail, 2020, 22(4):664-672.
[3] Eastwood GM, Nichol A. Optimal ventilator settings after return of spontaneous circulation[J]. Curr Opin Crit Care, 2020, 26(3):251-258.
[4] Sheu JJ, Tsai TH, Lee FY, et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock[J]. Crit Care Med, 2010, 38(9):1810-1817.
[5] Ouweneel DM, Schotborgh JV, Limpens J, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis[J]. Intensive Care Med, 2016, 42(12):1922-1934.
[6] Beurtheret S, Mordant P, Paoletti X, et al. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study(the cardiac-RESCUE program)[J]. Eur Heart J, 2013, 34(2):112-120.
[7] O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013, 61(4):485-510.
[8] Ibánez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Rev Esp Cardiol(Engl Ed), 2017, 70(12):1082.
[9] Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO(SAVE)-score[J]. Eur Heart J, 2015, 36(33):2246-2256.
[10] Schmidt M, Zogheib E, Rozé H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome[J]. Intensive Care Med, 2013, 39(10):1704-1713.
[11] Peigh G, Cavarocchi N, Keith SW, et al. Simple new risk score model for adult cardiac extracorporeal membrane oxygenation: simple cardiac ECMO score[J]. J Surg Res, 2015, 198(2):273-279.
[12] Cevasco M, Takayama H, Ando M, et al. Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation[J]. J Thorac Dis, 2019, 11(4):1676-1683.
[13] Lim HS, Howell N, Ranasinghe A. Extracorporeal life support: physiological concepts and clinical outcomes[J]. J Card Fail, 2017, 23(2):181-196.
[14] Ong CS, Hibino N. Left heart decompression in patients supported with extracorporeal membrane oxygenation for cardiac disease[J]. Postepy Kardiol Interwencyjnej, 2017, 13(1):1-2.
[15] Rao P, Khalpey Z, Smith R, et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest[J]. Circ Heart Fail, 2018, 11(9):e004905.
[16] Bréchot N, Luyt CE, Schmidt M, et al. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock[J]. Crit Care Med, 2013, 41(7):1616-1626.
[17] Petroni T, Harrois A, Amour J, et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation[J]. Crit Care Med, 2014, 42(9):2075-2082.
[18] Aso S, Matsui H, Fushimi K, et al. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database[J]. Crit Care Med, 2016, 44(11):1974-1979.
[19] Pappalardo F, Schulte C, Pieri M, et al. Concomitant implantation of Impella○R on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock[J]. Eur J Heart Fail, 2017, 19(3):404-412.
[20] Mégarbane B, Deye N, Aout M, et al. Usefulness of routine laboratory parameters in the decision to treat refractory cardiac arrest with extracorporeal life support[J]. Resuscitation, 2011, 82(9):1154-1161.
[21] Leick J, Liebetrau C, Szardien S, et al. Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest[J]. Clin Res Cardiol, 2013, 102(9):661-669.
[22] Brady WJ, Gurka KK, Mehring B, et al. In-hospital cardiac arrest: impact of monitoring and witnessed event on patient survival and neurologic status at hospital discharge[J]. Resuscitation, 2011, 82(7):845-852.
[23] Sinnah F, Dalloz MA, Magalhaes E, et al. Early electroencephalography findings in cardiogenic shock patients treated by venoarterial extracorporeal membrane oxygenation[J]. Crit Care Med, 2018, 46(5):e389-e394.
[24] Pozzebon S, Blandino OA, Franchi F, et al. Cerebral near-infrared spectroscopy in adult patients undergoing veno-arterial extracorporeal membrane oxygenation[J]. Neurocrit Care, 2018, 29(1):94-104.
[25] Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients[J]. Ann Thorac Surg, 2014, 97(2):610-616.
[26] Lamb KM, Dimuzio PJ, Johnson A, et al. Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation[J]. J Vasc Surg, 2017, 65(4):1074-1079.
[27] Juo YY, Skancke M, Sanaiha Y, et al. Efficacy of distal perfusion cannulae in preventing limb ischemia during extracorporeal membrane oxygenation: a systematic review and meta-analysis[J]. Artif Organs, 2017, 41(11):E263-E273.
[28] Hong D, Choi KH, Cho YH, et al. Multidisciplinary team approach in acute myocardial infarction patients undergoing veno-arterial extracorporeal membrane oxygenation[J]. Ann Intensive Care, 2020, 10(1):83.
[29] Gutsche JT, Vernick WJ. Cardiac and critical care anesthesiologists may be ideal members of the mobile ECMO team[J]. J Cardiothorac Vasc Anesth, 2016, 30(6):1439-1440.
[30] Becher PM, Goβling A, Schrage B, et al. Procedural volume and outcomes in patients undergoing VA-ECMO support[J]. Crit Care, 2020, 24(1):291.
[31] Corsi F, Lebreton G, Bréchot N, et al. Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation[J]. Crit Care, 2017, 21(1):76.
[32] Park TK, Yang JH, Jeon K, et al. Extracorporeal membrane oxygenation for refractory septic shock in adults[J]. Eur J Cardiothorac Surg, 2015, 47(2):e68-e74.
[33] Overtchouk P, Pascal J, Lebreton G, et al. Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support[J]. EuroIntervention, 2018, 13(18):e2160-e2168.
[34] Patricio D, Peluso L, Brasseur A, et al. Comparison of extracorporeal and conventional cardiopulmonary resuscitation: a retrospective propensity score matched study[J]. Crit Care, 2019, 23(1):27.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81600234)通信作者:吴辉,E-mail:cardiology_wh@126.com
更新日期/Last Update: 2021-03-20